An Overview of Pharmacovigilance in the Center for Drug Evaluation and Research (CDER)

FDA 

Credits: 1 

This webinar will give an overview of how the FDA conducts pharmacovigilance activities, detect safety signals, and communicates safety findings.

Define pharmacovigilance|Describe the Division of Pharmacovigilance’s (DPV’s) key safety roles in FDA’s Center for Drug Evaluation and Research (CDER)|Explain components of postmarketing drug safety surveillance|Describe the role of MedWatch for reporting postmarketing safety information|Discuss how adverse event reports are collected and analyzed by FDA/CDER/DPV 

FDA Drug Topics